Literature DB >> 16394697

Ultralong peripheral nerve block by lidocaine:prilocaine 1:1 mixture in a lipid depot formulation: comparison of in vitro, in vivo, and effect kinetics.

Lars Söderberg1, Henrik Dyhre, Bodil Roth, Sven Björkman.   

Abstract

BACKGROUND: The aim of this study was to develop stable and easily injectable lipid depot preparations of local anesthetics in which the drug concentration can be varied according to desired duration of action.
METHODS: The formulations contained a 2.0, 5.0, 10, 20, 40, 60, 80, or 100% eutectic mixture of lidocaine and prilocaine base in medium-chain triglyceride. Duration of sciatic nerve block and local neurotoxicity was investigated in rats with 2.0% lidocaine:prilocaine HCl solution and 99.5% ethanol as controls. The rate of release of local anesthetic from the site of administration and the possibility to predict in vivo depot characteristics from in vitro release data were investigated for the 20 and 60% formulations.
RESULTS: The duration of sensory sciatic block was prolonged 3 times with the 20% formulation and approximately 180 times with the 60% formulation, in comparison with the 2% aqueous solution. With the 80 and 100% formulations, all animals still showed nerve block after 2 weeks. The in vivo release of local anesthetic could be approximately predicted from in vitro data for the 20% but not for the 60% formulation. The formulations of 60% or greater and ethanol showed neurotoxic effects.
CONCLUSIONS: The pharmaceutical properties of these formulations compare favorably with those of other depot preparations. The high-percentage ones showed the longest duration of action yet reported for sciatic nerve block in rats. The possibility of using a high-concentration local anesthetic depot formulation as an alternative to ethanol or phenol for long-term nerve blocks in chronic pain merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394697     DOI: 10.1097/00000542-200601000-00017

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.

Authors:  Susan Weng Larsen; Claus Larsen
Journal:  AAPS J       Date:  2009-11-06       Impact factor: 4.009

2.  Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat.

Authors:  Chad M Brummett; Amrita K Padda; Francesco S Amodeo; Kathleen B Welch; Ralph Lydic
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

3.  Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat.

Authors:  Chad M Brummett; Mary A Norat; John M Palmisano; Ralph Lydic
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

4.  The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs.

Authors:  Brigitte M Richard; Paul Newton; Laura R Ott; Dean Haan; Abram N Brubaker; Phaedra I Cole; Paul E Ross; Marlon C Rebelatto; Keith G Nelson
Journal:  J Drug Deliv       Date:  2012-01-17

5.  Effects of perineural administration of dexmedetomidine in combination with levobupivacaine in a rat sciatic nerve block.

Authors:  Mehmet Ali Erdogan; Alaaddin Polat; Aytac Yucel; Mustafa Said Aydogan; Hakan Parlakpinar; Suat Tekin; Mahmut Durmus; Mehmet Ozcan Ersoy
Journal:  Curr Ther Res Clin Exp       Date:  2013-06

6.  Long-term effect of ropivacaine nanoparticles for sciatic nerve block on postoperative pain in rats.

Authors:  Zi Wang; Haizhen Huang; Shaozhong Yang; Shanshan Huang; Jingxuan Guo; Qi Tang; Feng Qi
Journal:  Int J Nanomedicine       Date:  2016-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.